Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 3/2012

01.03.2012 | Original Article

Prognostic significance of mediastinal 18F-FDG uptake in PET/CT in advanced ovarian cancer

verfasst von: Anne-Sophie Bats, Florent Hugonnet, Cyrille Huchon, Chérazade Bensaid, Nadia Pierquet-Ghazzar, Marc Faraggi, Fabrice Lécuru

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the prognostic significance of increased mediastinal 18F-FDG uptake in PET/CT for the staging of advanced ovarian cancer.

Methods

We retrospectively evaluated patients managed for FIGO stage III/IV ovarian cancer between 1 January 2006 and 1 June 2009. Patients were included if they had undergone 18F-FDG PET/CT and surgery for initial staging. Exclusion criteria were age younger than 18 years, inability to undergo general anaesthesia, recurrent ovarian cancer, and borderline or nonepithelial malignancy. Whole-body PET/CT was performed after intravenous 18F-FDG injection. The location of abnormal hot spots and 18F-FDG maximal standard uptake values (SUVmax) were recorded. We compared the complete cytoreduction and survival rates in groups defined based on mediastinal 18F-FDG uptake and SUVmax values. Kaplan-Meier curves of overall survival and disease-free survival were compared using the log-rank test. Hazard ratios with their 95% confidence intervals were computed. Adjusted hazard ratios were obtained using a multivariate Cox model.

Results

We included 53 patients, of whom 17 (32%) had increased mediastinal 18F-FDG uptake. Complete cytoreduction was achieved in 14 (87.5%) of the 16 patients managed with primary surgery and in 21 (75%) of the 28 patients managed with interval surgery. Complete cytoreduction was achieved significantly more often among patients without increased mediastinal 18F-FDG uptake (80.6% vs. 35.3%; p = 0.001). Disease-free survival was comparable between the two groups. By univariate analysis, overall mortality was significantly higher among patients with increased mediastinal 18F-FDG uptake (hazard ratio 5.70, 95% confidence interval 1.74–18.6). The only factor significantly associated with overall survival by multivariate analysis was complete cytoreduction (adjusted hazard ratio 0.24, 95% confidence interval 0.07–0.89).

Conclusion

Increased mediastinal 18F-FDG uptake was common in patients with advanced ovarian cancer. However, complete cytoreduction, which was significantly more frequent among patients without mediastinal 18F-FDG uptake, was the only factor independently associated with survival.
Literatur
1.
Zurück zum Zitat Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248–59.PubMedCrossRef Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20:1248–59.PubMedCrossRef
2.
Zurück zum Zitat Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol. 2003;90(2):390–6.PubMedCrossRef Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol. 2003;90(2):390–6.PubMedCrossRef
3.
Zurück zum Zitat Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol. 2006;103:559–64.PubMedCrossRef Chi DS, Eisenhauer EL, Lang J, Huh J, Haddad L, Abu-Rustum NR, et al. What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol. 2006;103:559–64.PubMedCrossRef
4.
Zurück zum Zitat Choi HJ, Roh JW, Seo SS, Lee S, Kim JY, Kim SK, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer. 2006;106:914–22.PubMedCrossRef Choi HJ, Roh JW, Seo SS, Lee S, Kim JY, Kim SK, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer. 2006;106:914–22.PubMedCrossRef
5.
Zurück zum Zitat Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer. 2007;110:1738–44.PubMedCrossRef Kidd EA, Siegel BA, Dehdashti F, Grigsby PW. The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival. Cancer. 2007;110:1738–44.PubMedCrossRef
6.
Zurück zum Zitat Risum S, Høgdall C, Loft A, Berthelsen A, Høgdall E, Nedergaard L, et al. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography – a prospective study. Gynecol Oncol. 2008;108:265–70.PubMedCrossRef Risum S, Høgdall C, Loft A, Berthelsen A, Høgdall E, Nedergaard L, et al. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography – a prospective study. Gynecol Oncol. 2008;108:265–70.PubMedCrossRef
7.
Zurück zum Zitat Avril N, Sassen S, Schmalfeldt B, Naehrig J, Rutke S, Weber W, et al. Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer. J Clin Oncol. 2005;23:7445–53.PubMedCrossRef Avril N, Sassen S, Schmalfeldt B, Naehrig J, Rutke S, Weber W, et al. Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer. J Clin Oncol. 2005;23:7445–53.PubMedCrossRef
8.
Zurück zum Zitat Nam E, Yun M, Oh Y, Kim J, Kim J, Kim S, et al. Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI. Gynecol Oncol. 2010;116:389–94.PubMedCrossRef Nam E, Yun M, Oh Y, Kim J, Kim J, Kim S, et al. Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI. Gynecol Oncol. 2010;116:389–94.PubMedCrossRef
9.
Zurück zum Zitat Risum S, Høgdall C, Loft A, Berthelsen A, Høgdall E, Nedergaard L, et al. Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer? Gynecol Oncol. 2010;116:395–8.PubMedCrossRef Risum S, Høgdall C, Loft A, Berthelsen A, Høgdall E, Nedergaard L, et al. Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer? Gynecol Oncol. 2010;116:395–8.PubMedCrossRef
10.
Zurück zum Zitat Deffieux X, Castaigne D, Pomel C. Role of laparoscopy to evaluate candidates for complete cytoreduction in advanced stages of epithelial ovarian cancer. Int J Gynecol Cancer. 2006;16 Suppl 1:35–40.PubMedCrossRef Deffieux X, Castaigne D, Pomel C. Role of laparoscopy to evaluate candidates for complete cytoreduction in advanced stages of epithelial ovarian cancer. Int J Gynecol Cancer. 2006;16 Suppl 1:35–40.PubMedCrossRef
11.
Zurück zum Zitat Chi DS, Abu-Rustum NR, Sonoda Y, Chen SW, Flores RM, Downey R, et al. The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions. Gynecol Oncol. 2004;94:307–11.PubMedCrossRef Chi DS, Abu-Rustum NR, Sonoda Y, Chen SW, Flores RM, Downey R, et al. The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions. Gynecol Oncol. 2004;94:307–11.PubMedCrossRef
12.
Zurück zum Zitat Cohen-Mouly S, Badia A, Bats AS, Barthes F, Bensaid C, Riquet M, et al. Role of video-assisted thoracoscopy in patients with ovarian cancer and pleural effusion. Int J Gynecol Cancer. 2009;19:1662–5.PubMedCrossRef Cohen-Mouly S, Badia A, Bats AS, Barthes F, Bensaid C, Riquet M, et al. Role of video-assisted thoracoscopy in patients with ovarian cancer and pleural effusion. Int J Gynecol Cancer. 2009;19:1662–5.PubMedCrossRef
13.
Zurück zum Zitat Kolev V, Mironov S, Mironov O, Ishill N, Moskowitz C, Gardner G, et al. Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2010;20:979–84.PubMedCrossRef Kolev V, Mironov S, Mironov O, Ishill N, Moskowitz C, Gardner G, et al. Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2010;20:979–84.PubMedCrossRef
14.
Zurück zum Zitat Souilamas R, Hidden G, Riquet M. Mediastinal lymphatic efferents from the diaphragm. Surg Radiol Anat. 2001;23:159–62.PubMedCrossRef Souilamas R, Hidden G, Riquet M. Mediastinal lymphatic efferents from the diaphragm. Surg Radiol Anat. 2001;23:159–62.PubMedCrossRef
15.
Zurück zum Zitat Okiemy G, Foucault C, Avisse C, Hidden G, Riquet M. Lymphatic drainage of the diaphragmatic pleura to the peritracheobronchial lymph nodes. Surg Radiol Anat. 2003;25:32–5.PubMedCrossRef Okiemy G, Foucault C, Avisse C, Hidden G, Riquet M. Lymphatic drainage of the diaphragmatic pleura to the peritracheobronchial lymph nodes. Surg Radiol Anat. 2003;25:32–5.PubMedCrossRef
16.
Zurück zum Zitat Rosenbaum SJ, Lind T, Antoch G, Bockisch A. False-positive FDG PET uptake – the role of PET/CT. Eur Radiol. 2006;16(5):1054–65.PubMedCrossRef Rosenbaum SJ, Lind T, Antoch G, Bockisch A. False-positive FDG PET uptake – the role of PET/CT. Eur Radiol. 2006;16(5):1054–65.PubMedCrossRef
17.
Zurück zum Zitat Lim M, Lee H, Jung D, Choi J, Seo S, Park S. Pathological diagnosis and cytoreduction of cardiophrenic lymph node and pleural metastasis in ovarian cancer patients using video-assisted thoracic surgery. Ann Surg Oncol. 2009;16:1990–6.PubMedCrossRef Lim M, Lee H, Jung D, Choi J, Seo S, Park S. Pathological diagnosis and cytoreduction of cardiophrenic lymph node and pleural metastasis in ovarian cancer patients using video-assisted thoracic surgery. Ann Surg Oncol. 2009;16:1990–6.PubMedCrossRef
Metadaten
Titel
Prognostic significance of mediastinal 18F-FDG uptake in PET/CT in advanced ovarian cancer
verfasst von
Anne-Sophie Bats
Florent Hugonnet
Cyrille Huchon
Chérazade Bensaid
Nadia Pierquet-Ghazzar
Marc Faraggi
Fabrice Lécuru
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 3/2012
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-011-1984-9

Weitere Artikel der Ausgabe 3/2012

European Journal of Nuclear Medicine and Molecular Imaging 3/2012 Zur Ausgabe